Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.60 |
| ▸ | MAOB | P27338 | 7/20 | 0.58 |
| ▸ | MAOA | P21397 | 2/20 | 0.57 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.57 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.54 |
| ▸ | RXRA | P19793 | 1/20 | 0.53 |
| ▸ | RXRB | P28702 | 1/20 | 0.53 |
| ▸ | RXRG | P48443 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935315 | 0.87 | ALOX5 (0.57) | ALOX5MAOBMAOASCN9AGID4 | |
| SCHEMBL9129586 | 0.87 | MAOB (0.76) | MAOBMAOASCN9A | |
| SCHEMBL963148 | 0.87 | MAOB (0.76) | MAOBMAOASCN9A | |
| SCHEMBL31060850 | 0.86 | MAOB (0.76) | MAOBMAOASCN9A | |
| SCHEMBL2018555 | 0.86 | MAOB (0.76) | MAOBMAOASCN9A | |
| SCHEMBL2185997 | 0.86 | MAOB (0.76) | MAOBMAOASCN9A | |
| SCHEMBL964395 | 0.86 | MAOB (0.76) | MAOBMAOASCN9A | |
| SCHEMBL7394431 | 0.86 | BCHE (0.57) | ALOX5MAOBMAOASCN9A | |
| SCHEMBL8935316 | 0.86 | BCHE (0.57) | ALOX5MAOBMAOASCN9A | |
| SCHEMBL7393828 | 0.85 | MAOB (0.58) | ALOX5MAOBMAOASCN9AGID4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5502079-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | FARMITALIA CARLO ERBA S.R.L. (IT) | 1996-03-26 | — | — | US | disclosed |